Breaking News Instant updates and real-time market news.

2022-01-21 07:01:36 HBAN Huntington Bancshares $16.66 / -0.445 (-2.60%) 07:01 01/21/22 01/21 07:01 01/21/22 07:01	Huntington Bancshares reports Q4 adjusted EPS 36c, consensus 32c Return on average assets was 0.92%, return on average common equity was 8.7%, return on average tangible common equity was 13.2%, and adjusted return on average tangible common equity was 18.2%. "We are very pleased with our performance for the full year, which included record revenue," said Steve Steinour, chairman, president and CEO. "Thanks to the efforts of our colleagues, we successfully executed on the largest acquisition in our history, while delivering continued organic growth aligned with our strategic objectives." "We delivered in the fourth quarter, finishing the year with record quarterly loan production, reflecting broad-based contributions across all commercial lending categories." said Steinour. "We enter 2022 increasingly confident in our outlook for growth in revenue and earnings. Commercial lending should fuel balance sheet growth in the coming year, while areas of strategic focus such as capital markets, cards and payments, and wealth management should bolster fee income. We remain committed to delivering sustainable revenue growth, annual positive operating leverage, and top-quartile returns."	21 Jan

2022-01-21 07:01:36

HBAN

Huntington Bancshares

$16.66 / -0.445 (-2.60%)

07:01

01/21/22

01/21

07:01

01/21/22

07:01

Huntington Bancshares reports Q4 adjusted EPS 36c, consensus 32c

Return on average assets was 0.92%, return on average common equity was 8.7%, return on average tangible common equity was 13.2%, and adjusted return on average tangible common equity was 18.2%. "We are very pleased with our performance for the full year, which included record revenue," said Steve Steinour, chairman, president and CEO. "Thanks to the efforts of our colleagues, we successfully executed on the largest acquisition in our history, while delivering continued organic growth aligned with our strategic objectives." "We delivered in the fourth quarter, finishing the year with record quarterly loan production, reflecting broad-based contributions across all commercial lending categories." said Steinour. "We enter 2022 increasingly confident in our outlook for growth in revenue and earnings. Commercial lending should fuel balance sheet growth in the coming year, while areas of strategic focus such as capital markets, cards and payments, and wealth management should bolster fee income. We remain committed to delivering sustainable revenue growth, annual positive operating leverage, and top-quartile returns."

21
Jan

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Bath & Body Works price target raised to $72 from $66 at Morgan Stanley » 06:11 08/19/22 08/19 06:11 08/19/22 06:11 BBWI Bath & Body Works $40.26 / +0.07 (+0.17%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options BBWI Bath & Body Works $40.26 / +0.07 (+0.17%) 08/17/22 Bath & Body Works saw declines in traffic trends in June, first part of July 08/17/22 Bath & Body Works recently cut 130 roles in home office organization 05/19/22 Bath & Body Works sees FY inflation impact $225M-$250M 05/19/22 Bath & Body Works to test new personal care line, including face and hair care BBWI Bath & Body Works $40.26 / +0.07 (+0.17%) 05:59 Today Barclays Bath & Body Works price target raised to $42 from $33 at Barclays 08/18/22 BMO Capital Bath & Body Works price target raised to $48 from $45 at BMO Capital 08/18/22 Baird Bath & Body Works price target raised to $48 from $40 at Baird 08/18/22 Wells Fargo Bath & Body Works price target raised to $50 from $45 at Wells Fargo BBWI Bath & Body Works $40.26 / +0.07 (+0.17%) 08/17/22 Bath & Body Works sees FY revenue down mid to high single digits vs. last year 08/17/22 Bath & Body Works sees Q3 sales down mid to high single digits vs. last year 08/17/22 Bath & Body Works sees FY22 EPS $2.70-$3.00, consensus $2.92 08/17/22 Bath & Body Works sees Q3 EPS 10c-20c, consensus 31c BBWI Bath & Body Works $40.26 / +0.07 (+0.17%) 08/18/22 What You Missed On Wall Street On Thursday 08/18/22 What You Missed On Wall Street This Morning 08/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/17/22 Fly Intel: After-Hours Movers BBWI Bath & Body Works $40.26 / +0.07 (+0.17%) 08/17/22 Bath & Body Works options imply 7.3% move in share price post-earnings 08/16/22 Early notable gainers among liquid option names on August 16th 07/20/22 Bath & Body Works put volume heavy and directionally bearish 07/06/22 Bath & Body Works put volume heavy and directionally bearish
Recommendations	Robinhood net sales 'slowed meaningfully' in July, says JPMorgan » 06:11 08/19/22 08/19 06:11 08/19/22 06:11 HOOD Robinhood $10.17 / -0.235 (-2.26%) Robinhood published its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options HOOD Robinhood $10.17 / -0.235 (-2.26%) 08/18/22 Robinhood reports Net Cumulative Funded Accounts at July-end 22.9M 08/08/22 Robinhood exec sells $1.18M in common stock 08/04/22 Robinhood CEO says in 'great position as a stand-alone company' 08/04/22 SEC probing Robinhood compliance with short selling rules HOOD Robinhood $10.17 / -0.235 (-2.26%) 08/12/22 Deutsche Bank Robinhood price target raised to $10 from $9 at Deutsche Bank 08/04/22 Deutsche Bank Robinhood price target raised to $9 from $8 at Deutsche Bank 08/04/22 Mizuho Robinhood price target lowered to $13 from $14 at Mizuho 08/03/22 Piper Sandler Robinhood price target lowered to $10 from $11 at Piper Sandler HOOD Robinhood $10.17 / -0.235 (-2.26%) 08/03/22 Notable companies reporting after market close 08/02/22 Robinhood reports Q2 EPS (34c), consensus (37c) 04/28/22 Robinhood reports Q1 EPS (45c), consensus (36c) 04/28/22 Notable companies reporting after market close HOOD Robinhood $10.17 / -0.235 (-2.26%) 08/11/22 Judge rules Robinhood must face market manipulation claims, Reuters says 07/20/22 Study finds Robinhood cause of phantom surge in Berkshire Hathaway, WSJ reports 06/27/22 Bankman-Fried says FTX not in active M&A talks with Robinhood, WSJ says 06/27/22 FTX deliberating about potential of deal to buy Robinhood, Bloomberg says HOOD Robinhood $10.17 / -0.235 (-2.26%) 08/11/22 What You Missed On Wall Street On Thursday 08/05/22 Here's What You Missed in Crypto This Week 08/03/22 Fly Intel: After-Hours Movers 08/03/22 What You Missed On Wall Street On Wednesday HOOD Robinhood $10.17 / -0.235 (-2.26%) 08/08/22 Robinhood Markets call volume above normal and directionally bullish 08/05/22 Unusually active option classes on open August 5th 08/04/22 Robinhood Markets call volume above normal and directionally bullish 08/04/22 Unusually active option classes on open August 4th
Recommendations	Nemaura Medical price target lowered to $8 from $12 at H.C. Wainwright » 06:09 08/19/22 08/19 06:09 08/19/22 06:09 NMRD Nemaura Medical $2.18 / -0.04 (-1.80%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NMRD Nemaura Medical $2.18 / -0.04 (-1.80%) 07/21/22 Nemaura Medical granted UK trademark for 'Meta Sore,' a digital biomarker term 05/17/22 Nemaura Medical says MySugarWatch continues sugarBEAT awareness campaign 05/03/22 MySugarWatch launches physician-focused ads in MIMS NMRD Nemaura Medical $2.18 / -0.04 (-1.80%) 03/29/22 H.C. Wainwright Nemaura Medical initiated with a Buy at H.C. Wainwright NMRD Nemaura Medical $2.18 / -0.04 (-1.80%) 08/15/22 Nemaura Medical reports Q1 EPS (17c) vs (14c) last year 06/30/22 Nemaura Medical reports 2022 EPS (59c), consensus (58c) NMRD Nemaura Medical $2.18 / -0.04 (-1.80%) 06/30/22 What You Missed On Wall Street On Thursday 09:00 Today Nemaura Medical Inc.
Recommendations	Globant price target raised to $249 from $231 at Piper Sandler » 06:08 08/19/22 08/19 06:08 08/19/22 06:08 GLOB Globant $230.39 / +0.92 (+0.40%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events GLOB Globant $230.39 / +0.92 (+0.40%) 05/02/22 AgileThought names Singh as Chief Financial Officer 04/20/22 Globant acquires low-code platform GeneXus, terms not disclosed 03/30/22 Globant drops 7% to $256.26 after disclosing code breach 03/30/22 Globant trading resumes GLOB Globant $230.39 / +0.92 (+0.40%) 07/18/22 Piper Sandler Globant price target raised to $231 from $223 at Piper Sandler 05/20/22 Cowen Globant price target lowered to $240 from $305 at Cowen 05/20/22 Citi Globant price target lowered to $265 from $350 at Citi 05/20/22 Piper Sandler Globant price target lowered to $223 from $339 at Piper Sandler GLOB Globant $230.39 / +0.92 (+0.40%) 08/18/22 Globant sees FY22 non-IFRS adjusted EPS at least $5.03, consensus $4.99 08/18/22 Globant sees Q3 non-IFRS adjusted diluted EPS at least $1.24, consensus $1.24 08/18/22 Globant reports Q2 non-IFRS EPS $1.22, consensus $1.19 05/19/22 Globant sees FY22 adjusted EPS at least $4.94, consensus $4.96 GLOB Globant $230.39 / +0.92 (+0.40%) 08/18/22 Fly Intel: After-Hours Movers 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 08/30/22 Mexico Tech Services Field Trip
Recommendations	Bill.com price target raised to $215 from $170 at Piper Sandler » 06:07 08/19/22 08/19 06:07 08/19/22 06:07 BILL Bill.com $149.71 / -1.85 (-1.22%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options BILL Bill.com $149.71 / -1.85 (-1.22%) 08/18/22 Bill.com names Sofya Pogreb COO 08/15/22 Lone Pine buys Booking, exits Snap in Q2 07/20/22 Bill.com CFO sells $3.8M in common stock 05/19/22 Bill.com rises 16.6% BILL Bill.com $149.71 / -1.85 (-1.22%) 05:55 Today KeyBanc Bill.com price target raised to $200 from $150 at KeyBanc 04:57 Today Keefe Bruyette Bill.com price target raised to $269 from $245 at Keefe Bruyette 04:47 Today Oppenheimer Bill.com price target raised to $200 from $150 at Oppenheimer 04:45 Today Jefferies Bill.com price target raised to $180 from $150 at Jefferies BILL Bill.com $149.71 / -1.85 (-1.22%) 08/18/22 Bill.com sees FY23 adjusted EPS 23c-38c, consensus (34c) 08/18/22 Bill.com sees Q1 adjusted EPS 5c-7c, consensus (9c) 08/18/22 Bill.com reports Q4 adjusted EPS (3c), consensus (13c) 05/05/22 Bill.com sees FY22 EPS (35c)-(34c), consensus (46c) 22 Sep BILL Bill.com $149.71 / -1.85 (-1.22%) 08/18/22 Fly Intel: After-Hours Movers 06/12/22 Sell these stocks now, proven algorithm says 06/03/22 Sell these stocks now, proven algorithm says 05/20/22 What You Missed On Wall Street On Friday BILL Bill.com $149.71 / -1.85 (-1.22%) 08/18/22 Bill.com Holdings options imply 11.0% move in share price post-earnings 05/12/22 Bill.com Holdings put volume heavy and directionally bearish 05/05/22 Bill.com Holdings options imply 14.0% move in share price post-earnings
Recommendations	Meta Platforms price target lowered to $225 from $280 at Morgan Stanley » 06:07 08/19/22 08/19 06:07 08/19/22 06:07 META Meta Platforms $174.61 / -0.13 (-0.07%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options META Meta Platforms $174.61 / -0.13 (-0.07%) 08/15/22 Lone Pine buys Booking, exits Snap in Q2 08/15/22 David Tepper's Appaloosa buys Salesforce, exits Nordstrom in Q2 08/15/22 Tiger Global buys Alphabet Class A, exits Zoom Video in Q2 08/11/22 Teens are leaving Facebook, YouTube used by 95% of teens, Pew Research says META Meta Platforms $174.61 / -0.13 (-0.07%) 08/11/22 Loop Capital Loop Capital has 'stronger conviction' in Enovix after 'customer milestones' 08/10/22 BofA Meta Platforms added to US 1 List; Alphabet removed at BofA 08/09/22 Stifel Unity price target raised to $60 at Stifel after AppLovin proposal 08/05/22 Needham Meta Platforms outlook made worse by Apple's AdTech platform, says Needham META Meta Platforms $174.61 / -0.13 (-0.07%) 07/27/22 Meta Platforms reports Q2 EPS $2.46, consensus $2.61 07/27/22 Notable companies reporting after market close META Meta Platforms $174.61 / -0.13 (-0.07%) 08/17/22 New TikTok feature lets creator share Stories to Facebook and Instagram, TC says 08/17/22 Amazon beta testing 'TikTok-like feed' with employees, WSJ says 08/15/22 Scion Asset Management exits all stocks and adds only Geo Group, Bloomberg says 08/15/22 Meta invests in Singaporean startup Take App, TechCrunch says META Meta Platforms $174.61 / -0.13 (-0.07%) 08/17/22 #SocialStocks: FTC expected to expand online privacy, data protections 08/10/22 #SocialStocks: Musk sells Tesla shares should he lose legal battle with Twitter 08/05/22 What You Missed On Wall Street On Friday 08/03/22 #SocialStocks: Five-day trial between Twitter and Elon Musk set for October 17 META Meta Platforms $174.61 / -0.13 (-0.07%) 07/29/22 Notable open interest changes for July 29th 07/29/22 Meta Platforms Inc call buyer realizes 44% same-day gains 07/28/22 Notable open interest changes for July 28th 07/27/22 Meta Platforms Inc options imply 8.6% move in share price post-earnings
Recommendations	Silver Spike Investment price target lowered to $14 from $17 at Piper Sandler » 06:06 08/19/22 08/19 06:06 08/19/22 06:06 SSIC Silver Spike Investment $9.30 / +0.1 (+1.09%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate SSIC Silver Spike Investment $9.30 / +0.1 (+1.09%) 03/01/22 Piper Sandler Silver Spike Investment initiated with an Overweight at Piper Sandler 03/01/22 Stifel Silver Spike Investment initiated with a Hold at Stifel SSIC Silver Spike Investment $9.30 / +0.1 (+1.09%) 08/12/22 Silver Spike Investment reports Q1 NII 4c vs. ($425.03) last year 04 Feb
Recommendations	Hain Celestial price target lowered to $28 from $31 at Piper Sandler » 06:05 08/19/22 08/19 06:05 08/19/22 06:05 HAIN Hain Celestial $24.80 / +0.14 (+0.57%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate Events HAIN Hain Celestial $24.80 / +0.14 (+0.57%) 06/16/22 Piper Sandler Hain Celestial price target lowered to $31 from $36 at Piper Sandler 05/24/22 CL King Hain Celestial initiated with a Buy at CL King 05/23/22 Cowen Hain Celestial initiated with an Outperform at Cowen 05/09/22 Mizuho Hain Celestial price target lowered to $31 from $44 at Mizuho HAIN Hain Celestial $24.80 / +0.14 (+0.57%) 08/09/22 Hain Celestial sees FY23 low single digit adjusted net sales growth 08/09/22 Hain Celestial sees Q4 revenue approximately $457M, consensus $478.45M 05/05/22 Hain Celestial sees 2022 flat adjusted net sales, consensus $1.95B 05/05/22 Hain Celestial sees Q4 low to mid single digital adjusted net sales growth 11 Nov 08/25/22 Hain Celestial - HAIN
Hot Stocks	Immuron to deprioritize SARS-CoV-2 research, focus on advanced drug candidates » 06:04 08/19/22 08/19 06:04 08/19/22 06:04 IMRN Immuron $2.58 / -0.04 (-1.53%) Immuron announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News IMRN Immuron $2.58 / -0.04 (-1.53%) 07/26/22 Immuron reports feedback from FDA regarding IND targeting Campylobacter and ETEC 07/11/22 Immuron reports FY22 North American Travelan sales up 494% 07/07/22 Immuron granted European patent for treatment of Clostridioides difficile 05/09/22 Immuron provides update on Travelan clinical trial in Travelers' Diarrhea
Downgrade	Provident Financial downgraded to Neutral from Overweight at Piper Sandler » 06:04 08/19/22 08/19 06:04 08/19/22 06:04 PFS Provident Financial $25.57 / +0.07 (+0.27%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings PFS Provident Financial $25.57 / +0.07 (+0.27%) 07/12/22 Provident Financial announces $475,000 in NRTC funding awards 07/06/22 SB One Insurance Agency rebranded as Provident Protection Plus 06/16/22 Provident Financial extends reach to Long Island with new Roslyn branch 04/11/22 Provident Bank enters partnership with Yankees Radio Network PFS Provident Financial $25.57 / +0.07 (+0.27%) 07/29/22 Provident Financial reports Q2 EPS 53c, consensus 52c 04/29/22 Provident Financial reports Q1 EPS 58c, consensus 46c

Recommendations	Versus Systems price target lowered to $1.50 from $2.50 at H.C. Wainwright » 06:02 08/19/22 08/19 06:02 08/19/22 06:02 VS Versus Systems / + H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research VS Versus Systems / + 08/02/22 Versus Systems completes activation for Finastra 07/28/22 Versus Systems launches Zaxby's PLAYMUSICITYGP.COM promotion 07/26/22 Versus Systems announces USPTO granted new patent claims 07/22/22 Versus Systems signs first television contract for team-focused channel VS Versus Systems / + 04/29/22 H.C. Wainwright Versus Systems price target lowered to $2.50 from $3.50 at H.C. Wainwright 03/18/22 H.C. Wainwright Versus Systems price target lowered to $3.50 from $5 at H.C. Wainwright 11/23/21 H.C. Wainwright Versus Systems price target lowered to $5 from $7 at H.C. Wainwright
Hot Stocks	Ucommune International announces adjournment of Extraordinary General Meeting » 06:02 08/19/22 08/19 06:02 08/19/22 06:02 UK Ucommune International $5.26 / -0.26 (-4.71%) Ucommune International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><<
Hot Stocks	Sprague Resources expects to close merger by September 1 » 06:01 08/19/22 08/19 06:01 08/19/22 06:01 SRLP Sprague Resources $18.92 / +0.01 (+0.05%) Sprague Resources… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly SRLP Sprague Resources $18.92 / +0.01 (+0.05%) 06/03/22 Sprague Resources rises 19.7% 06/03/22 Sprague Resources rises 19.8% 06/03/22 Sprague Resources rises 19.8% 06/02/22 Sprague Resources to be acquired by Hartree for $19.00 per share SRLP Sprague Resources $18.92 / +0.01 (+0.05%) 03/03/22 Sprague Resources reports Q4 EPS $1.66, one estimate 34c SRLP Sprague Resources $18.92 / +0.01 (+0.05%) 06/02/22 Fly Intel: After-Hours Movers
Recommendations	ZIM Integrated price target lowered to $63 from $76 at Barclays » 06:01 08/19/22 08/19 06:01 08/19/22 06:01 ZIM ZIM Integrated $51.49 / +3.645 (+7.62%) Barclays analyst Alexia… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ZIM ZIM Integrated $51.49 / +3.645 (+7.62%) 08/17/22 ZIM Integrated falls -8.5% 08/17/22 ZIM Integrated raises quarterly dividend to 4.75 per share 08/01/22 ZIM Integrated invests $5M in scanning technology developer Sodyo 06/08/22 ZIM Integrated falls -11.0% ZIM ZIM Integrated $51.49 / +3.645 (+7.62%) 07/20/22 Jefferies ZIM Integrated initiated with a Hold at Jefferies 07/01/22 BofA ZIM Integrated downgraded to Underperform from Buy at BofA 06/17/22 JPMorgan ZIM Integrated upgraded to Neutral from Underweight at JPMorgan 05/12/22 Citi Citi opens 'positive Catalyst Watch' on ZIM Integrated into Q1 ZIM ZIM Integrated $51.49 / +3.645 (+7.62%) 08/17/22 ZIM Integrated backs FY22 adjusted EBITDA view $7.8B-$8.2B 08/17/22 ZIM Integrated reports Q2 EPS $11.07, consensus $12.84 05/18/22 ZIM Integrated raises FY22 adjusted EBITDA view to $7.8B-$8.2B from $7.1B-$7.5B 05/18/22 ZIM Integrated reports Q1 EPS $14.19 vs. $5.13 a year ago ZIM ZIM Integrated $51.49 / +3.645 (+7.62%) 08/17/22 Fly Intel: Pre-market Movers 07/01/22 What You Missed On Wall Street On Friday 07/01/22 What You Missed On Wall Street This Morning ZIM ZIM Integrated $51.49 / +3.645 (+7.62%) 08/08/22 ZIM Integrated Shipping Services call volume above normal and directionally bullish 07/22/22 ZIM Integrated Shipping Services call volume above normal and directionally bullish 07/07/22 ZIM Integrated Shipping Services put volume heavy and directionally bearish 07/05/22 ZIM Integrated Shipping Services put volume heavy and directionally bearish
Hot Stocks	Volvo Group Deputy CEO Jan Gurander to step down » 06:01 08/19/22 08/19 06:01 08/19/22 06:01 VLVLY Volvo $17.29 / -0.17 (-0.97%) Jan Gurander will step… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals VLVLY Volvo $17.29 / -0.17 (-0.97%) 08/09/22 Starbucks, Volvo,ChargePoint team on EV charger spots on Denver to Seattle route 07/26/22 Beam Global, Volvo announces partnership to offer off-grid EV charging 07/08/22 Volvo, Daimler Truck and Traton kick off European charging infrastructure JV 06/28/22 Group of 34 companies ask California Governor to allow autonomous trucks VLVLY Volvo $17.29 / -0.17 (-0.97%) 07/28/22 HSBC Volvo downgraded to Hold from Buy at HSBC 07/26/22 UBS Volvo price target raised to SEK 162 from SEK 151 at UBS 07/20/22 RBC Capital Volvo price target raised to SEK 229 from SEK 226 at RBC Capital 06/28/22 RBC Capital Volvo price target raised to SEK 226 from SEK 224 at RBC Capital VLVLY Volvo $17.29 / -0.17 (-0.97%) 07/19/22 Volvo reports Q2 EPS SEK 5.14 vs. SEK 4.38 last year 04/22/22 Volvo reports Q1 EPS SEK 3.46 vs. SEK 4.35 last year VLVLY Volvo $17.29 / -0.17 (-0.97%) 06/29/22 Waymo, others call on CA to lift ban on heavy self-driving trucks, Verge says 03/24/22 Volvo's Polestar's hazy branding may become liability, NY Times reports
Recommendations	TJX price target raised to $76 from $72 at Barclays » 06:00 08/19/22 08/19 06:00 08/19/22 06:00 TJX TJX $68.03 / -0.515 (-0.75%) Barclays analyst Adrienne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TJX TJX $68.03 / -0.515 (-0.75%) 08/17/22 TJX: Q3 QTD SSS tracking similar to Q3 guidance 08/17/22 TJX expects to repurchase $2.25B-$2.5B of TJX stock this FY 08/17/22 TJX committed to returning to pre-Covid pretax margin of 10.6% within 3 years 08/17/22 TJX: U.S. averge basket up in Q2, U.S. customer traffic down TJX TJX $68.03 / -0.515 (-0.75%) 08/18/22 Cowen TJX price target raised to $77 from $72 at Cowen 08/18/22 Baird TJX price target raised to $77 from $74 at Baird 08/16/22 Deutsche Bank Macy's price target lowered to $25 from $29 at Deutsche Bank 08/03/22 OTR Global Ross Stores upgraded to Positive from Mixed view at OTR Global TJX TJX $68.03 / -0.515 (-0.75%) 08/17/22 TJX sees Q3 revenue $12.1B-$12.3B, consensus $12.92B 08/17/22 TJX cuts FY23 revenue view to $49.6B-$49.9B from $51.3B-$51.8B 08/17/22 TJX sees Q4 adjusted EPS 92c-96c 08/17/22 TJX backs FY23 adjusted EPS view $3.13-$3.20 TJX TJX $68.03 / -0.515 (-0.75%) 05/21/22 TJX among off-price retailers looking like bargains, Barron's says TJX TJX $68.03 / -0.515 (-0.75%) 08/17/22 What You Missed On Wall Street On Wednesday 08/17/22 What You Missed On Wall Street This Morning 08/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/07/22 What You Missed On Wall Street This Morning TJX TJX $68.03 / -0.515 (-0.75%) 06/28/22 TJX call volume above normal and directionally bullish 05/20/22 TJX put volume heavy and directionally bearish 05/18/22 Early notable gainers among liquid option names on May 18th 05/18/22 Unusually active option classes on open May 18th
General news	FX Action: » 06:00 08/19/22 08/19 06:00 08/19/22 06:00 $ECON Economic Data / + FX Action: The DXY dollar… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 08/18/22 Fed's Bullard tells WSJ leaning toward another 75 point hike 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says $ECON Economic Data / + 08/17/22 What You Missed On Wall Street On Wednesday 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning
Recommendations	Clorox price target raised to $101 from $93 at Barclays » 06:00 08/19/22 08/19 06:00 08/19/22 06:00 CLX Clorox $148.74 / +0.005 (+0.00%) Barclays analyst Lauren… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options CLX Clorox $148.74 / +0.005 (+0.00%) 08/03/22 Clorox drops 6% to $136.19 after FY23 guidance trails estimates 08/03/22 Clorox announces streamlined operating model 08/03/22 Clorox CEO says 'looking to fiscal year 2023, the environment remains difficult' 07/12/22 Clorox raises quarterly dividend 2% to $1.18 from $1.16 per share CLX Clorox $148.74 / +0.005 (+0.00%) 08/04/22 Morgan Stanley Clorox price target lowered to $130 from $137 at Morgan Stanley 08/04/22 Credit Suisse Clorox price target lowered to $130 from $140 at Credit Suisse 07/25/22 Deutsche Bank Clorox price target raised to $135 from $132 at Deutsche Bank 07/21/22 JPMorgan Clorox price target raised to $132 from $127 at JPMorgan CLX Clorox $148.74 / +0.005 (+0.00%) 08/03/22 Clorox sees FY23 adjusted EPS $3.85-$4.22, consensus $5.26 08/03/22 Clorox reports Q4 adjusted EPS 93c, consensus 93c 08/03/22 Notable companies reporting after market close 05/02/22 Clorox cuts FY22 adjusted EPS view to $4.05-$4.30 from $4.25-$4.50 CLX Clorox $148.74 / +0.005 (+0.00%) 08/03/22 Fly Intel: After-Hours Movers 07/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/02/22 Fly Intel: After-Hours Movers CLX Clorox $148.74 / +0.005 (+0.00%) 07/05/22 Clorox put volume heavy and directionally bearish 06/22/22 Clorox call volume above normal and directionally bullish 05/31/22 Clorox put volume heavy and directionally bearish 05/24/22 Clorox call volume above normal and directionally bullish
Recommendations	Bath & Body Works price target raised to $42 from $33 at Barclays » 05:59 08/19/22 08/19 05:59 08/19/22 05:59 BBWI Bath & Body Works $40.26 / +0.07 (+0.17%) Barclays analyst Adrienne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options BBWI Bath & Body Works $40.26 / +0.07 (+0.17%) 08/17/22 Bath & Body Works saw declines in traffic trends in June, first part of July 08/17/22 Bath & Body Works recently cut 130 roles in home office organization 05/19/22 Bath & Body Works sees FY inflation impact $225M-$250M 05/19/22 Bath & Body Works to test new personal care line, including face and hair care BBWI Bath & Body Works $40.26 / +0.07 (+0.17%) 08/18/22 BMO Capital Bath & Body Works price target raised to $48 from $45 at BMO Capital 08/18/22 Baird Bath & Body Works price target raised to $48 from $40 at Baird 08/18/22 Wells Fargo Bath & Body Works price target raised to $50 from $45 at Wells Fargo 08/18/22 Credit Suisse Bath & Body Works price target lowered to $42 from $49 at Credit Suisse BBWI Bath & Body Works $40.26 / +0.07 (+0.17%) 08/17/22 Bath & Body Works sees FY revenue down mid to high single digits vs. last year 08/17/22 Bath & Body Works sees Q3 sales down mid to high single digits vs. last year 08/17/22 Bath & Body Works sees FY22 EPS $2.70-$3.00, consensus $2.92 08/17/22 Bath & Body Works sees Q3 EPS 10c-20c, consensus 31c BBWI Bath & Body Works $40.26 / +0.07 (+0.17%) 08/18/22 What You Missed On Wall Street On Thursday 08/18/22 What You Missed On Wall Street This Morning 08/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/17/22 Fly Intel: After-Hours Movers BBWI Bath & Body Works $40.26 / +0.07 (+0.17%) 08/17/22 Bath & Body Works options imply 7.3% move in share price post-earnings 08/16/22 Early notable gainers among liquid option names on August 16th 07/20/22 Bath & Body Works put volume heavy and directionally bearish 07/06/22 Bath & Body Works put volume heavy and directionally bearish
Hot Stocks	Verona Pharma: Nuance Pharma cleared by CDE to begin trials with ensifentrine » 05:58 08/19/22 08/19 05:58 08/19/22 05:58 VRNA Verona Pharma $12.81 / +0.78 (+6.48%) Verona Pharma announces… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly VRNA Verona Pharma $12.81 / +0.78 (+6.48%) 08/09/22 Verona Pharma surges after ensifentrine meets endpoint in COPD study 08/08/22 Verona Pharma to announce top-line data from Phase 3 trial of Ensifentrine 06/09/22 Verona Pharma completes enrollment in Phase 3 ENHANCE-1 trial 05/09/22 Verona Pharma to present successful TQT analysis of ensifentrine VRNA Verona Pharma $12.81 / +0.78 (+6.48%) 08/09/22 Canaccord Verona Pharma price target raised to $27 from $24 at Canaccord 08/09/22 Wedbush Verona Pharma price target raised to $23 from $18 at Wedbush 06/17/22 Wedbush Verona Pharma price target lowered to $18 from $25 at Wedbush 09/13/21 Fly Intel: Top five analyst initiations VRNA Verona Pharma $12.81 / +0.78 (+6.48%) 08/09/22 Verona Pharma reports Q2 EPS (4c), consensus (38c) 11 Aug VRNA Verona Pharma $12.81 / +0.78 (+6.48%) 08/09/22 What You Missed On Wall Street On Tuesday 08/09/22 What You Missed On Wall Street This Morning 08/08/22 Fly Intel: After-Hours Movers

Recommendations	Autodesk price target raised to $263 from $216 at Barclays » 05:58 08/19/22 08/19 05:58 08/19/22 05:58 ADSK Autodesk $228.77 / +0.53 (+0.23%) Barclays analyst Saket… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ADSK Autodesk $228.77 / +0.53 (+0.23%) 06/16/22 Autodesk names Ruth Ann Keene as Chief Legal Officer 03/24/22 Autodesk to acquire The Wild, terms not disclosed ADSK Autodesk $228.77 / +0.53 (+0.23%) 08/17/22 Mizuho Autodesk price target raised to $290 from $250 at Mizuho 08/16/22 Wolfe Research Procore initiated with a Peer Perform at Wolfe Research 08/16/22 Wolfe Research Autodesk initiated with an Outperform at Wolfe Research 07/26/22 Oppenheimer Autodesk initiated with an Outperform at Oppenheimer ADSK Autodesk $228.77 / +0.53 (+0.23%) 05/26/22 Autodesk sees FY23 non-GAAP EPS $6.43-$6.66, consensus $6.69 05/26/22 Autodesk sees Q2 non-GAAP EPS $1.54 - $1.60, consensus $1.60 05/26/22 Autodesk reports Q1 non-GAAP EPS $1.43, consensus $1.34 05/26/22 Notable companies reporting after market close ADSK Autodesk $228.77 / +0.53 (+0.23%) 08/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/26/22 Fly Intel: After-Hours Movers 05/23/22 What You Missed On Wall Street On Monday 05/23/22 What You Missed On Wall Street This Morning 08/24/22 Autodesk - ADSK ADSK Autodesk $228.77 / +0.53 (+0.23%) 05/27/22 Early notable gainers among liquid option names on May 27th 05/26/22 Autodesk options imply 6.4% move in share price post-earnings 04/25/22 Unusually active option classes on open April 25th
Recommendations	Apple price target raised to $185 from $177 at KeyBanc » 05:57 08/19/22 08/19 05:57 08/19/22 05:57 AAPL Apple $174.16 / -0.415 (-0.24%) KeyBanc analyst Brandon… KeyBanc analyst Brandon Nispel raised the firm's price target on Apple to $185 from $177 and keeps an Overweight rating on the shares. The analyst recommends owning Apple and raised the price target "based on strong trends." Keybanc's data "rapidly rebounded" post the company's softer results in April through June, Nispel tells investors in a research note. July is seasonally the strongest sequential growth month of Apple's fiscal Q4, which appears to be off to a strong start, says the analyst. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AAPL Apple $174.16 / -0.415 (-0.24%) 08/15/22 Berkshire Hathaway exits Verizon, cuts GM in Q2 08/03/22 Microsoft says Teams now optimized for Mac computers 07/28/22 Apple says 'constantly surveilling' the market for potential acquisitions 07/28/22 Apple expects Q4 revenue to accelerate y/y AAPL Apple $174.16 / -0.415 (-0.24%) 08/17/22 Wedbush Apple price target raised to $220 from $200 at Wedbush 08/17/22 Susquehanna Lumentum optical reacceleration a 2023 story, says Susquehanna 08/16/22 Credit Suisse Apple upgraded to Outperform from Neutral at Credit Suisse 08/11/22 Craig-Hallum Enovix price target raised to $25 from $20 at Craig-Hallum AAPL Apple $174.16 / -0.415 (-0.24%) 07/28/22 Apple reports Q3 EPS $1.20, consensus $1.16 07/28/22 Notable companies reporting after market close 04/28/22 Apple says y/y Q3 revenue growth to be impacted by COVID 04/28/22 Apple reports Q2 EPS $1.52, consensus $1.43 AAPL Apple $174.16 / -0.415 (-0.24%) 08/17/22 Apple targeting Sept. 7 for iPhone 14 launch event, Bloomberg says 08/17/22 Apple targeting Sept. 7 for iPhone 14 launch event, Bloomberg says 08/17/22 Apple in talks with suppliers to make Apple Watch in Vietnam, Nikkei Asia says 08/16/22 Apple lays off about 100 recruiter contractors, Bloomberg reports AAPL Apple $174.16 / -0.415 (-0.24%) 08/17/22 What You Missed On Wall Street On Wednesday 08/17/22 #SocialStocks: FTC expected to expand online privacy, data protections 08/17/22 What You Missed On Wall Street This Morning 08/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations AAPL Apple $174.16 / -0.415 (-0.24%) 08/18/22 Notable open interest changes for August 18th 08/17/22 Notable open interest changes for August 17th 08/16/22 Notable open interest changes for August 16th 08/16/22 Apple put buyer realizes 2% same-day gains
Hot Stocks	Aurora Mobile partners with 55Haitao.com » 05:56 08/19/22 08/19 05:56 08/19/22 05:56 JG Aurora Mobile / + Aurora Mobile announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research JG Aurora Mobile / + 06/08/22 Aurora Mobile launches Overseas Messaging Cloud Solution 05/11/22 Aurora Mobile expands partnership with global new energy vehicle manufacturer 04/21/22 Li Auto, KE Holdings among new additions to SEC HFCAA provisional list JG Aurora Mobile / + 06/09/22 Alliance Global Partners Aurora Mobile downgraded on demand pressure at Alliance Global Partners 06/09/22 Alliance Global Partners Aurora Mobile downgraded to Neutral from Buy at Alliance Global Partners 03/03/22 Alliance Global Partners Aurora Mobile price target lowered to $2.25 from $3.00 at Alliance Global Partners 11/23/21 Alliance Global Partners Aurora Mobile assumed with a Buy at Alliance Global Partners
Recommendations	Bill.com price target raised to $200 from $150 at KeyBanc » 05:55 08/19/22 08/19 05:55 08/19/22 05:55 BILL Bill.com $149.71 / -1.85 (-1.22%) KeyBanc analyst Josh Beck… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options BILL Bill.com $149.71 / -1.85 (-1.22%) 08/18/22 Bill.com names Sofya Pogreb COO 08/15/22 Lone Pine buys Booking, exits Snap in Q2 07/20/22 Bill.com CFO sells $3.8M in common stock 05/19/22 Bill.com rises 16.6% BILL Bill.com $149.71 / -1.85 (-1.22%) 04:57 Today Keefe Bruyette Bill.com price target raised to $269 from $245 at Keefe Bruyette 04:47 Today Oppenheimer Bill.com price target raised to $200 from $150 at Oppenheimer 04:45 Today Jefferies Bill.com price target raised to $180 from $150 at Jefferies 07/26/22 Oppenheimer Bill.com assumed with an Outperform at Oppenheimer BILL Bill.com $149.71 / -1.85 (-1.22%) 08/18/22 Bill.com sees FY23 adjusted EPS 23c-38c, consensus (34c) 08/18/22 Bill.com sees Q1 adjusted EPS 5c-7c, consensus (9c) 08/18/22 Bill.com reports Q4 adjusted EPS (3c), consensus (13c) 05/05/22 Bill.com sees FY22 EPS (35c)-(34c), consensus (46c) 22 Sep BILL Bill.com $149.71 / -1.85 (-1.22%) 08/18/22 Fly Intel: After-Hours Movers 06/12/22 Sell these stocks now, proven algorithm says 06/03/22 Sell these stocks now, proven algorithm says 05/20/22 What You Missed On Wall Street On Friday BILL Bill.com $149.71 / -1.85 (-1.22%) 08/18/22 Bill.com Holdings options imply 11.0% move in share price post-earnings 05/12/22 Bill.com Holdings put volume heavy and directionally bearish 05/05/22 Bill.com Holdings options imply 14.0% move in share price post-earnings
Earnings	Vipshop sees Q3 revenue down 10%-15% y/y, consensus $3.54B » 05:55 08/19/22 08/19 05:55 08/19/22 05:55 VIPS Vipshop $9.63 / -0.175 (-1.79%) For the third quarter,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events VIPS Vipshop $9.63 / -0.175 (-1.79%) 03/31/22 Vipshop announces $1B share repurchase program 02/23/22 Vipshop falls -10.9% VIPS Vipshop $9.63 / -0.175 (-1.79%) 05/20/22 Citi Citi downgrades Vipshop to Sell with second half rebound visibility low 05/20/22 Citi Vipshop downgraded to Sell from Neutral at Citi 03/14/22 JPMorgan Vipshop price target lowered to $7 from $9 at JPMorgan 03/07/22 Morgan Stanley JD.com price target lowered to $85 from $98 at Morgan Stanley VIPS Vipshop $9.63 / -0.175 (-1.79%) 05:54 Today Vipshop reports Q2 adjusted EPS 37c, consensus 20c 05/19/22 Vipshop sees Q2 revenue down 20%-25%, consensus $4.55B 05/19/22 Vipshop reports Q1 EPS 33c, consensus 31c 02/23/22 Vipshop sees Q1 revenue down 5% to flat, one estimate $4.83B VIPS Vipshop $9.63 / -0.175 (-1.79%) 03/16/22 Chinese stocks jump as Beijing vows to keep markets stable, Reuters reports VIPS Vipshop $9.63 / -0.175 (-1.79%) 03/31/22 What You Missed On Wall Street This Morning 03/31/22 Fly Intel: Pre-market Movers 03/16/22 What You Missed On Wall Street On Wednesday 03/16/22 What You Missed On Wall Street This Morning 08/24/22 UBS Tech Week: TMI & Digital Assets Conference 07:30 Today Vipshop - VIPS

Events

Earnings calls, analyst events, roadshows and more

VIPS
Today at 07:30

Vipshop - VIPS Conference Calls
ELV
Today at 08:00

Elevance Health Firm Sponsored Meetings

Company Headquarters--220 Virginia Avenue, Indianapolis, IN
RNW
Today at 08:30

ReNew Energy Global - RNW Conference Calls
VJET
Today at 08:30

Voxeljet - VJET Conference Calls
FL
Today at 09:00

Foot Locker - FL Conference Calls
IGIC
Today at 09:00

International General Insurance - IGIC Conference Calls
KAL
Today at 09:00

Kalera - KAL Conference Calls
NVGS
Today at 09:00

Navigator Holdings - NVGS Conference Calls
NMRD
Today at 09:00

Nemaura Medical Inc. Firm Sponsored Meetings
ALJJ
Today at 09:00

ALJ Regional Holdings Inc. Firm Sponsored Meetings

599 Lexington Ave, New York, NY

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	BROS X BROS Dutch Bros Block Trade Managers: Morgan Stanley Priced at: $43.50 5.97M Shares GRFX X GRFX Graphex Group IPO Managers: EF Hutton Priced at: $2.50 4.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LUCY X LUCY Innovative Eyewear IPO Managers: Maxim Priced at: $7.50 980K Shares SVFD X SVFD Save Foods Secondary Managers: ThinkEquity Priced at: $3.00 1.6M Shares FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: Goldman Sachs & SVB Securities, Stifel, Oppenheimer Priced at: $7.82 9.591M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TELA X TELA Tela Bio Spot Secondary Managers: Lake Street Priced at: $8.00 4M Shares TRIN X TRIN Trinity Capital Spot Secondary Managers: Keefe Bruyette, Morgan Stanley, UBS & Wells Fargo Priced at: $15.33 3.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	BE X BE Bloom Energy Secondary Managers: JPMorgan, Morgan Stanley & BofA Priced at: $26.00 13M Shares VRDN X VRDN Viridian Therapeutics Secondary Managers: Jefferies, SVB Securities & Evercore ISI Priced at: $23.50 9.628M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLE X ASLE AerSale Spot Secondary Managers: Cowen, RBC Capital & Stifel, Truist Priced at: $17.25 4.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OPCH X OPCH Option Care Health Spot Secondary Managers: Goldman Sachs Priced at: $33.25 11M Shares OSH X OSH Oak Street Health Spot Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley, William Blair & Piper Sandler Priced at: $25.75 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	GCT X GCT GigaCloud IPO Managers: Aegis Priced at: $12.25 29.04M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFRX X GFRX Graphex Group Secondary Managers: EF Hutton Priced at: $2.50 4.7M Shares UBX X UBX Unity Biotechnology Secondary Managers: SVB Securities, Cantor Fitzgerald & Mizuho, Wedbush Priced at: $.70 64.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	DVAX X DVAX Dynavax Block Trade Managers: Goldman Sachs $14.85-15.62 3M Shares
Tues	No deals
Wed	No deals
Thurs	CGRN X CGRN Capstone Green Energy Spot Secondary Managers: Lake Street, Joseph Gunnar $3.94
Fri	No deals

View All Syndicate Announcements »

Huntington Bancshares reports Q4 adjusted EPS 36c, consensus 32c

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access